Orange Book product · Brand (NDA)

CANASA

MESALAMINE

Brand (NDA)NDA 021252TE ABRX ABBVIE

Nov 05, 2004

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
Nov 05, 2004
21 yr 11 mo ago
Today
Patent 8217083 expires
Listed drug product patent expiration.
Jun 06, 2028
in 2 yr
Patent 8436051 expires
Listed drug product patent expiration.
Jun 06, 2028
in 2 yr

Active ingredient

MESALAMINE

Strength

1GM

Dosage form

SUPPOSITORY

Route

RECTAL

TE code

Application

NDA 021252

Product number

002

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
8217083	Jun 06, 2028	in 2 yr	Product
8436051	Jun 06, 2028	in 2 yr	Product